Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,708 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Recruiting

A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

NCT06192563

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Investigational Site Number: 002 Bologna, Italy
  • Investigational Site Number: 006 Brescia, Italy
  • Investigational Site Number: 004 Florence, Italy
  • Investigational Site Number: 001 Milan, Italy
View Trial Details
Recruiting

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

NCT07266805

Conditions
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH), Acquired angioedema, Angioedema, +15 more
Locations
  • Study Site San Diego, California, United States
  • Study Site Walnut Creek, California, United States
  • Study Site St Louis, Missouri, United States
  • Study Site Hershey, Pennsylvania, United States
View all 32 locations
View Trial Details
Recruiting

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

NCT07015996

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology Little Rock, Arkansas, United States
  • University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy Los Angeles, California, United States
  • Johns Hopkins Children's Center: Department of Allergy & Immunology Baltimore, Maryland, United States
  • Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit Boston, Massachusetts, United States
View Trial Details
Recruiting

Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy

NCT07030881

Conditions
Asthma, Asthma, COPD, Bronchial Diseases, +12 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The Second Affiliated Hospital of Harbin Medical University Harbin, China
  • Anhui Chest Hospital Hefei, China
  • Beilun District Second People's Hospital Ningbo, China
View Trial Details
Recruiting

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

NCT06664619

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12087 Phoenix, Arizona, United States
  • Teva Investigational Site 12144 Phoenix, Arizona, United States
  • Teva Investigational Site 12104 Tucson, Arizona, United States
  • Teva Investigational Site 12146 Tucson, Arizona, United States
View all 183 locations
View Trial Details
Recruiting

UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

NCT07349212

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +5 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Flinders Medical Center Bedford Park, South Australia, Australia
  • The Royal Melbourne Hospital Fitzroy, Victoria, Australia
  • Fiona Stanley Hospital Perth, Western Australia, Australia
View Trial Details
Recruiting

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

NCT07456033

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Aventura, Florida, United States
  • GSK Investigational Site Kissimmee, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View Trial Details

Related conditions